2016 Ethics Networking Pharma 
Pharma Marketing Network
MAY 6, 2023
While AI can be a powerful tool for creating effective marketing campaigns, it also poses significant ethical challenges. One of the main ethical concerns with using AI in pharmaceutical marketing is the potential for the technology to perpetuate biases and discrimination. AI Ethics: The Importance of Fairness.” Crown, 2016. (3)
Pharma Marketing Network
DECEMBER 17, 2021
Big pharma has compelling reasons to change the way business gets done. Johnson & Johnson was one of the first major companies to make a public commitment to the SDGs in 2016. Company policies, like the code of ethical conduct, are examples of governance that typically stem from the corporate level. Ethics is a skill.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaKinnex
AUGUST 23, 2022
The Traditional Pharma Model Isn’t Working – It’s Time to Evolve! The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. What are these new and existing pharma regulations, expectations, and challenges? COVID-19, Telemedicine, & The New Pharma Landscape.
Pharma Marketing Network
MAY 15, 2023
Additionally, companies must ensure that the data they collect is accurate and reliable, and that it is used ethically and responsibly. 1 (2016) 3. The post The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges appeared first on Pharma Marketing Network. 8 (2018) 2. Hardoon and Susan E.
Pharma Marketing Network
MARCH 23, 2023
Additionally, companies must ensure that the data they collect is accurate and reliable, and that it is used ethically and responsibly. 1 (2016) 3. The post The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges appeared first on Pharma Marketing Network. 8 (2018) 2. Hardoon and Susan E.
Clarify Health
DECEMBER 13, 2022
The first is the 21st Century Cures Act signed into law in 2016 and the second is the COVID-19 pandemic, which drove the use of RWD and RWE, at scale. About 10% of pharma companies at this point have active efforts but we’ve started to see some approvals. I think the pandemic sped that up a bit.
Clarify Health
DECEMBER 13, 2022
The first is the 21st Century Cures Act signed into law in 2016 and the second is the COVID-19 pandemic, which drove the use of RWD and RWE, at scale. About 10% of pharma companies at this point have active efforts but we’ve started to see some approvals. I think the pandemic sped that up a bit.
Expert insights. Personalized for you.
52 
Let's personalize your content